Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy targetKamal Mandal, Arun P. Wiita, Gianina Wicaksono et al.|Nature Cancer|2023Cited by 39
Abstract 4820: Anti-CD72 nanobody-based CAR-T affinity maturation leads to improved in vitro efficacy versus low antigen density lymphoma models, but limited benefit in vivoAdila Izgutdina, Arun P. Wiita, Tasfia Rashid et al.|Cancer Research|2025Cited by 1
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell MalignanciesAdila Izgutdina, Arun P. Wiita, H Takamatsu et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1